Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Overview

Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Topic type

Condition

Category

Oncology

MeSH classification

C04.557.337.539.250|C15.378.190.636.370|C15.378.508.539.250|C23.550.291.500.485

Preparing for an appointment about Leukemia, Myelogenous, Chronic, BCR-ABL Positive

If you are speaking with a healthcare professional about Leukemia, Myelogenous, Chronic, BCR-ABL Positive, it can help to prepare a few details in advance.

• Write down your symptoms and when they started.
• Bring details of any medicines, supplements or previous treatments.
• Ask what tests or assessments may be needed.
• Ask what treatment or management options may be suitable.
• Ask when you should seek urgent medical help or follow-up care.

Finding care related to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.